For example, prostate cancer cells derived from bone metastases overexpress protease-activated receptor 1 (PAR1), a thrombin receptor that enables CTCs to interact with platelets and to form protective heterotypic clusters (Figure 5A) [144,145]. Here, F2R is linked to prostate carcinoma.